Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China · Delayed Price · Currency is CNY 12.69
-0.09 (-0.70%)
Aug 14, 2026, 3:04 PM CST
SHE:300601 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 169.31 | 257.3 | 432.84 | 1,196 | 1,018 | 3,550 |
Short-Term Investments | - | 715.97 | 2,174 | 463.34 | 531.58 | 725.57 |
Trading Asset Securities | 1,711 | 1,689 | - | 100.02 | 440.83 | - |
Cash & Short-Term Investments | 1,881 | 2,662 | 2,607 | 1,759 | 1,990 | 4,275 |
Cash Growth | 755.12% | 2.12% | 48.21% | -11.61% | -53.45% | 40.73% |
Accounts Receivable | 2,752 | 2,584 | 2,787 | 2,788 | 2,293 | 1,858 |
Other Receivables | 11.43 | 11.16 | 10.54 | 8.9 | 11.38 | 14.25 |
Receivables | 2,764 | 2,595 | 2,798 | 2,797 | 2,305 | 1,872 |
Inventory | 693.73 | 681.09 | 782.77 | 772.85 | 727.8 | 1,058 |
Other Current Assets | 618.28 | 56.66 | 55.09 | 67.51 | 152.34 | 135.14 |
Total Current Assets | 5,957 | 5,995 | 6,242 | 5,396 | 5,175 | 7,341 |
Property, Plant & Equipment | 4,868 | 4,965 | 5,225 | 5,716 | 5,176 | 4,116 |
Long-Term Investments | 0 | 0 | - | 311.68 | 302.38 | 105.64 |
Other Intangible Assets | 497.26 | 467.9 | 436.66 | 433.45 | 357.98 | 346.04 |
Long-Term Deferred Tax Assets | 683.15 | 689.49 | 697.63 | 630.32 | 708.32 | 558.6 |
Long-Term Deferred Charges | 277.99 | 299.2 | 268.26 | 172.47 | 195.95 | 489.6 |
Other Long-Term Assets | 1,703 | 1,679 | 1,693 | 2,425 | 1,871 | 1,192 |
Total Assets | 13,986 | 14,095 | 14,564 | 15,085 | 13,786 | 14,149 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 571.06 | 708.25 | 847.83 | 882.48 | 434.13 | 708.2 |
Accrued Expenses | 54.07 | 1,280 | 1,358 | 1,595 | 1,330 | 807.26 |
Short-Term Debt | 11.01 | - | 34.1 | 60.04 | 170.07 | 777.53 |
Current Portion of Long-Term Debt | 25.53 | 16.66 | 202.95 | 32.32 | 103.61 | 22.6 |
Current Income Taxes Payable | 17.62 | - | 6.32 | - | - | 65.64 |
Current Unearned Revenue | 24.6 | 40.86 | 19.28 | 28.76 | 31.23 | 94.51 |
Other Current Liabilities | 1,371 | 169.68 | 178.17 | 152.69 | 270.96 | 142.39 |
Total Current Liabilities | 2,075 | 2,216 | 2,647 | 2,751 | 2,340 | 2,618 |
Long-Term Debt | 1,890 | 1,870 | 1,786 | 2,372 | 2,016 | 1,938 |
Long-Term Unearned Revenue | 258.3 | 262.21 | 247.82 | 328.7 | 383.1 | 349.54 |
Long-Term Deferred Tax Liabilities | 0.67 | 0.67 | 34.52 | 26.89 | 26.08 | 41.47 |
Other Long-Term Liabilities | 97.1 | 115.42 | 186.72 | 64.51 | 36.33 | 35.13 |
Total Liabilities | 4,321 | 4,464 | 4,903 | 5,544 | 4,801 | 4,982 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,117 | 1,117 | 1,117 | 1,117 | 1,120 | 687.09 |
Additional Paid-In Capital | 5,512 | 5,512 | 5,511 | 5,369 | 5,490 | 5,357 |
Retained Earnings | 2,526 | 2,492 | 2,523 | 2,544 | 1,884 | 2,612 |
Treasury Stock | - | - | - | - | -20 | -0.55 |
Comprehensive Income & Other | 510.79 | 510.83 | 510.95 | 511.1 | 511.14 | 511.3 |
Total Common Equity | 9,665 | 9,632 | 9,661 | 9,542 | 8,985 | 9,167 |
Minority Interest | 0.11 | -0.16 | -0.1 | - | - | - |
Shareholders' Equity | 9,665 | 9,632 | 9,661 | 9,542 | 8,985 | 9,167 |
Total Liabilities & Equity | 13,986 | 14,095 | 14,564 | 15,085 | 13,786 | 14,149 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,927 | 1,887 | 2,024 | 2,465 | 2,289 | 2,738 |
Net Cash (Debt) | -46.13 | 775.57 | 583.32 | -705.64 | -299.34 | 1,537 |
Net Cash Growth | - | 32.96% | - | - | - | -47.84% |
Net Cash Per Share | -0.04 | 0.66 | 0.52 | -0.63 | -0.27 | 1.38 |
Filing Date Shares Outstanding | 1,117 | 1,117 | 1,117 | 1,117 | 1,120 | 1,120 |
Total Common Shares Outstanding | 1,117 | 1,117 | 1,117 | 1,117 | 1,120 | 1,099 |
Working Capital | 3,882 | 3,779 | 3,595 | 2,645 | 2,835 | 4,723 |
Book Value Per Share | 8.65 | 8.62 | 8.65 | 8.54 | 8.02 | 8.34 |
Tangible Book Value | 9,168 | 9,164 | 9,224 | 9,108 | 8,627 | 8,821 |
Tangible Book Value Per Share | 8.21 | 8.20 | 8.26 | 8.15 | 7.70 | 8.02 |
Buildings | - | 2,751 | 2,780 | 2,718 | 1,037 | 939.37 |
Machinery | - | 3,185 | 2,840 | 1,853 | 1,671 | 1,682 |
Construction In Progress | - | 711.43 | 990.28 | 2,281 | 3,463 | 2,320 |